177Lu-FAP-2286 Combined Chemotherapy in a Case of Thymus Nonkeratinizing Squamous Carcinoma With Superior Vena Cava Syndrome
We reported a 52-year-old man with thymus nonkeratinized squamous carcinoma presenting with acute superior vena cava syndrome (SVCS) who received 177Lu-FAP-2286 treatment and followed by low-dose chemotherapy. 68Ga-FAP-2286 PET/CT revealed significantly less intensity of the mediastinal mass comparing to pretherapy scan, as well as significant relief of SVCS. No adverse effects were observed.
Authors
- Yingwei Wang
- Jia Deng
- Yueqing Chen
- Tingting Xu (ORCID: https://orcid.org/0000-0001-5524-035X)
Institutions
- Target (United States) (US)
- Southwest Medical University (CN)
- Affiliated Hospital of Southwest Medical University (CN)
Publication Details
- Journal
- Clinical Nuclear Medicine
- Published
- 2026-02-03
- DOI
- https://doi.org/10.1097/rlu.0000000000006350
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 0.00